Full Text
A markov model to assess the incremental cost effectiveness ratio for optimal statin utilization as compared with current use- An analysis of medicaid beneficiaries having type-2 diabetes

Abstract

Authors

M. Regine S. Kogut

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×